ECM
VIR icon

Everence Capital Management’s Vir Biotechnology VIR Stock Holding History

Everence Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,780
Closed -$96K – 1039
2024
Q3 		$96K Sell
12,780
-8,650
-40% -$75.1K 0.01% 744
2024
Q2 		$181 Hold
21,430
– – 0.01% 697
2024
Q1 		$217 Hold
21,430
– – 0.01% 689
2023
Q4 		$216K Hold
21,430
– – 0.02% 679
2023
Q3 		$201 Buy
21,430
+11,260
+111% +$161K 0.02% 674
2023
Q2 		$271K Hold
10,170
– – 0.02% 560
2023
Q1 		$237 Hold
10,170
– – 0.02% 622
2022
Q4 		$257 Hold
10,170
– – 0.02% 595
2022
Q3 		$196K Hold
10,170
– – 0.02% 660
2022
Q2 		$259K Buy
+10,170
New +$237K 0.02% 562

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return